Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring ...
DexCom reported Q4 revenue of $1.26 billion (up 13% YoY) and finished the year above the high end of guidance, delivering a non‑GAAP gross margin of 63.5%, adjusted EBITDA margin of 33.5%, net income ...
DexCom (NASDAQ:DXCM) is gearing up to announce its quarterly earnings on Thursday, 2026-02-12. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
People have been riding the GLP-1 wave to achieve quick and significant weight loss. But given the drug’s effect on controlling type 2 diabetes, it’s no surprise that DexCom CEO Jake Leach wants to ...
Korea is a market with not only high medical standards but also very high interest in health and acceptance of new technology by global standards. That is why Dexcom, which leads the global continuous ...
DexCom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, DexCom has captured an impressive slice of ...
The CGM provides real-time glucose readings for 15.5 days. “As a disabled veteran living with Type 2 diabetes, becoming a grandfather has given me a powerful new reason to take charge of my health,” ...
Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...
NEWPORT NEWS, Va. — The U.S. Army has taken a significant step to modernize how it manages Soldiers’ training data. On Nov. 15, ATIS Training — a streamlined, intuitive platform for managing ...
DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...
SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported third-quarter net income of $283.8 million. The San Diego-based company said it had net income of 70 cents per share. Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results